Pharming Group Nv (PHAR)
NASDAQ:PHAR
Want to see PHAR full AI Analyst Report?
| Dec 25 | Dec 24 | Dec 23 | Dec 22 | Dec 21 | |
|---|---|---|---|---|---|
| Income Statement | |||||
| Total Revenue | $ 377.18M | $ 307.75M | $ 245.32M | $ 205.62M | $ 225.46M |
| Gross Profit | $ 331.56M | $ 271.09M | $ 220.10M | $ 188.06M | $ 201.49M |
| Operating Income | $ 19.37M | $ -8.93M | $ -5.39M | $ 18.23M | $ 15.37M |
| EBITDA | $ 30.62M | $ 16.89M | $ 9.88M | $ 33.53M | $ 55.30M |
| Net Income | $ 2.86M | $ -12.26M | $ -10.55M | $ 13.67M | $ 18.13M |
| Balance Sheet | |||||
| Cash & Short-Term Investments | $ 179.81M | $ 173.85M | $ 213.42M | $ 207.34M | $ 217.59M |
| Total Assets | $ 499.81M | $ 414.18M | $ 462.85M | $ 425.80M | $ 450.44M |
| Total Debt | $ 115.78M | $ 116.30M | $ 171.54M | $ 166.69M | $ 183.39M |
| Net Debt | $ -30.25M | $ 59.41M | $ 109.80M | $ -40.65M | $ -34.20M |
| Total Liabilities | $ 222.79M | $ 185.27M | $ 244.07M | $ 221.16M | $ 231.73M |
| Stockholders' Equity | $ 277.02M | $ 228.91M | $ 218.78M | $ 204.64M | $ 218.71M |
| Cash Flow | |||||
| Free Cash Flow | $ 49.31M | $ -2.68M | $ -18.77M | $ 20.48M | $ 23.95M |
| Operating Cash Flow | $ 50.07M | $ -1.86M | $ -17.30M | $ 22.46M | $ 42.90M |
| Investing Cash Flow | $ 18.43M | $ 32.74M | $ -129.39M | $ 5.32M | $ -24.15M |
| Financing Cash Flow | $ 14.48M | $ -35.63M | $ -1.04M | $ -4.98M | $ -31.68M |